QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR

QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR
Reuters - 9 hours ago
Company on Track to Initiate Phase 1 Study by EOY 2009 SYDNEY and BEDMINSTER, NJ, Oct. 12 /PRNewswire-FirstCall/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual ...
QRxPharma inks agreement with TSX-listed Patheon - Proactive Investors Australia